These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
307 related articles for article (PubMed ID: 30328290)
1. Protein imbalance in the development of skeletal muscle wasting in tumour-bearing mice. Brown JL; Lee DE; Rosa-Caldwell ME; Brown LA; Perry RA; Haynie WS; Huseman K; Sataranatarajan K; Van Remmen H; Washington TA; Wiggs MP; Greene NP J Cachexia Sarcopenia Muscle; 2018 Oct; 9(5):987-1002. PubMed ID: 30328290 [TBL] [Abstract][Full Text] [Related]
2. Mitochondrial degeneration precedes the development of muscle atrophy in progression of cancer cachexia in tumour-bearing mice. Brown JL; Rosa-Caldwell ME; Lee DE; Blackwell TA; Brown LA; Perry RA; Haynie WS; Hardee JP; Carson JA; Wiggs MP; Washington TA; Greene NP J Cachexia Sarcopenia Muscle; 2017 Dec; 8(6):926-938. PubMed ID: 28845591 [TBL] [Abstract][Full Text] [Related]
3. Cathepsin K activity controls cachexia-induced muscle atrophy via the modulation of IRS1 ubiquitination. Meng X; Huang Z; Inoue A; Wang H; Wan Y; Yue X; Xu S; Jin X; Shi GP; Kuzuya M; Cheng XW J Cachexia Sarcopenia Muscle; 2022 Apr; 13(2):1197-1209. PubMed ID: 35098692 [TBL] [Abstract][Full Text] [Related]
4. Targeting RAGE prevents muscle wasting and prolongs survival in cancer cachexia. Chiappalupi S; Sorci G; Vukasinovic A; Salvadori L; Sagheddu R; Coletti D; Renga G; Romani L; Donato R; Riuzzi F J Cachexia Sarcopenia Muscle; 2020 Aug; 11(4):929-946. PubMed ID: 32159297 [TBL] [Abstract][Full Text] [Related]
5. Cancer cachexia in a mouse model of oxidative stress. Brown JL; Lawrence MM; Ahn B; Kneis P; Piekarz KM; Qaisar R; Ranjit R; Bian J; Pharaoh G; Brown C; Peelor FF; Kinter MT; Miller BF; Richardson A; Van Remmen H J Cachexia Sarcopenia Muscle; 2020 Dec; 11(6):1688-1704. PubMed ID: 32918528 [TBL] [Abstract][Full Text] [Related]
6. Transcriptomic analysis of the development of skeletal muscle atrophy in cancer-cachexia in tumor-bearing mice. Blackwell TA; Cervenka I; Khatri B; Brown JL; Rosa-Caldwell ME; Lee DE; Perry RA; Brown LA; Haynie WS; Wiggs MP; Bottje WG; Washington TA; Kong BC; Ruas JL; Greene NP Physiol Genomics; 2018 Dec; 50(12):1071-1082. PubMed ID: 30289747 [TBL] [Abstract][Full Text] [Related]
7. Corylifol A ameliorates muscle atrophy by inhibiting TAOK1/p38-MAPK/FoxO3 pathway in cancer cachexia. Zhang R; Shen Q; Wang Y; Deng X; Fan J; Gu X; Fan M; Wei K; Cheng CR; Zhang WD; Zhang XW; Liu X J Cachexia Sarcopenia Muscle; 2023 Oct; 14(5):2098-2113. PubMed ID: 37439183 [TBL] [Abstract][Full Text] [Related]
8. Valproic acid attenuates skeletal muscle wasting by inhibiting C/EBPβ-regulated atrogin1 expression in cancer cachexia. Sun R; Zhang S; Hu W; Lu X; Lou N; Yang Z; Chen S; Zhang X; Yang H Am J Physiol Cell Physiol; 2016 Jul; 311(1):C101-15. PubMed ID: 27122162 [TBL] [Abstract][Full Text] [Related]
9. REDD1 deletion attenuates cancer cachexia in mice. Hain BA; Xu H; VanCleave AM; Gordon BS; Kimball SR; Waning DL J Appl Physiol (1985); 2021 Dec; 131(6):1718-1730. PubMed ID: 34672766 [TBL] [Abstract][Full Text] [Related]
10. JNK signaling contributes to skeletal muscle wasting and protein turnover in pancreatic cancer cachexia. Mulder SE; Dasgupta A; King RJ; Abrego J; Attri KS; Murthy D; Shukla SK; Singh PK Cancer Lett; 2020 Oct; 491():70-77. PubMed ID: 32735910 [TBL] [Abstract][Full Text] [Related]
11. Toll-like receptor 4 mediates Lewis lung carcinoma-induced muscle wasting via coordinate activation of protein degradation pathways. Zhang G; Liu Z; Ding H; Miao H; Garcia JM; Li YP Sci Rep; 2017 May; 7(1):2273. PubMed ID: 28536426 [TBL] [Abstract][Full Text] [Related]
12. Growth of ovarian cancer xenografts causes loss of muscle and bone mass: a new model for the study of cancer cachexia. Pin F; Barreto R; Kitase Y; Mitra S; Erne CE; Novinger LJ; Zimmers TA; Couch ME; Bonewald LF; Bonetto A J Cachexia Sarcopenia Muscle; 2018 Aug; 9(4):685-700. PubMed ID: 30009406 [TBL] [Abstract][Full Text] [Related]
13. Skeletal muscle glycoprotein 130's role in Lewis lung carcinoma-induced cachexia. Puppa MJ; Gao S; Narsale AA; Carson JA FASEB J; 2014 Feb; 28(2):998-1009. PubMed ID: 24145720 [TBL] [Abstract][Full Text] [Related]
14. Ameliorating cancer cachexia by inhibiting cancer cell release of Hsp70 and Hsp90 with omeprazole. Liu Z; Xiong J; Gao S; Zhu MX; Sun K; Li M; Zhang G; Li YP J Cachexia Sarcopenia Muscle; 2022 Feb; 13(1):636-647. PubMed ID: 34729960 [TBL] [Abstract][Full Text] [Related]
15. A novel orthotopic mouse model replicates human lung cancer cachexia. van de Worp WRPH; Theys J; González AS; van der Heyden B; Verhaegen F; Hauser D; Caiment F; Smeets HJM; Schols AMWJ; van Helvoort A; Langen RCJ J Cachexia Sarcopenia Muscle; 2023 Jun; 14(3):1410-1423. PubMed ID: 37025071 [TBL] [Abstract][Full Text] [Related]
17. Effect of the specific proteasome inhibitor bortezomib on cancer-related muscle wasting. Penna F; Bonetto A; Aversa Z; Minero VG; Rossi Fanelli F; Costelli P; Muscaritoli M J Cachexia Sarcopenia Muscle; 2016 Jun; 7(3):345-54. PubMed ID: 27239411 [TBL] [Abstract][Full Text] [Related]
18. ZIP4 Promotes Muscle Wasting and Cachexia in Mice With Orthotopic Pancreatic Tumors by Stimulating RAB27B-Regulated Release of Extracellular Vesicles From Cancer Cells. Yang J; Zhang Z; Zhang Y; Ni X; Zhang G; Cui X; Liu M; Xu C; Zhang Q; Zhu H; Yan J; Zhu VF; Luo Y; Hagan JP; Li Z; Fang J; Jatoi A; Fernandez-Zapico ME; Zheng L; Edil BH; Bronze MS; Houchen CW; Li YP; Li M Gastroenterology; 2019 Feb; 156(3):722-734.e6. PubMed ID: 30342032 [TBL] [Abstract][Full Text] [Related]